Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global RNA Therapeutics Market Investment Analysis and Growth Report 2023-2035: Innovators Landscape, Analysis of Investments and Company Valuation, Business Risks, Opportunity Analysis, Acquisitions

      Research_and_Markets_Logo

      News provided by

      Research and Markets

      Apr 24, 2023, 06:15 ET

      Share this article

      Share this article


      DUBLIN, April 24, 2023 /PRNewswire/ -- The "Investor Series: Opportunities in RNA Therapeutics Market" report has been added to ResearchAndMarkets.com's offering.

      The Investor Series: Opportunities in RNA Therapeutics Market report provides detailed information on the RNA therapeutics market, covering the various types of RNA therapeutics, including RNAi therapies, RNA aptamers, and mRNA therapies and mRNA vaccines. It offers a technical and financial perspective on how the opportunity in this domain is likely to evolve, in terms of future business success, till 2035.

      RNA therapies have emerged as a promising treatment modality, with the potential to target and alter genes, modulate protein function and broaden the range of druggable targets, thereby, paving way for new avenues in disease diagnosis and treatment. Foreseeing these opportunities, numerous start-ups have been established in the last few years, indicating the growing interest in this sector.

      Owing to the rising demand for better therapeutic options and increasing adoption rate of such therapies, the investment focus for RNA therapeutics has increased significantly. In fact, since 2011, a total of over USD 16 billion was raised by RNA-based drug developers to advance their pipeline candidates.

      It is worth highlighting that, amongst the RNA therapeutics investors, majority of the investments have been led by mRNA vaccines investors and mRNA therapeutics investors. This is followed by RNAi therapeutics investors and RNA aptamers investors. Driven by the rise in government initiatives for early commercialization of pipeline therapeutics and active involvement of RNA therapeutics investors, we anticipate a variety of novel RNA based therapeutics to be developed, presenting lucrative investment opportunities for both short- and long-term investors.

      Scope of the Report

      The information in this report has been presented across multiple deliverables, featuring MS Excel sheets (some of which include interactive elements) and a MS PowerPoint deck, which summarizes the key takeaways from the project and insights drawn from the curated data.

      Key Questions Answered

      • What are the key advantages offered by RNA therapies and vaccines?
      • Which drugs are being evaluated across early and late stages of pipeline?
      • Which are the key therapeutic areas targeted by RNA therapeutics
      • What type of therapies that are being offered by the innovator companies?
      • What are the key value propositions offered by players engaged in the RNA therapeutics domain?
      • What is the relative competitiveness of different players engaged in the development of RNA therapeutics?
      • Who are the key investors that are actively supporting the development and commercialization of RNA therapeutics?
      • What are the anticipated fundamental and technical trends of financial data of publicly listed companies within the innovator landscape?
      • Who are the potential acquisition targets for investors in the RNA therapeutics domain?
      • What are the major risks for investors seeking to tap into the RNA therapeutics domain?
      • What is the estimated return on investments received by the investors?
      • How is the current and future market opportunity related to RNA therapeutics likely to be distributed across key market segments?

      Key Topics Covered:

      EXCEL DELIVERABLE

      1. INNOVATORS AND PRODUCTS DATASET
      1.1. Analysis Notes
      1.2. Innovators Landscape
      1.3. Products Landscape
      1.4. Value Proposition
      1.5. Key Acquisition Targets
      1.6. Appendices

      2. FUNDING AND INVESTMENT ANALYSIS
      2.1. Analysis Notes
      2.2. Summary Dashboard
      2.3. Capital Investments in RNA Therapeutics
      2.4 Appendices

      3. COMPANY VALUATION ANALYSIS
      3.1. Analysis Notes
      3.2. Sample Data Analysis
      3.3. Company Valuation
      3.4. Appendices

      4. FUNDAMENTAL FINANCIAL ANALYSIS
      4.1. Analysis Notes
      4.2. Summary Dashboard
      4.3. Company Fundamentals
      4.4. Fundamental Analysis
      4.5. Appendices

      5. TECHNICAL FINANCIAL ANALYSIS
      5.1. Analysis Notes
      5.2. Key Highlights
      5.3. Open High Low Close Chart / Stock Price & Volume Traded (Last 100 Days)
      5.4. 5 Day Moving Average (Buy & Sell Signals)
      5.5. 10 Day Moving Average (Buy & Sell Signals)
      5.6. 50 Day Moving Average (Buy & Sell Signals)
      5.7. Bollinger Bands
      5.8. Relative Strength Index
      5.9. Average Directional Index
      5.10. Commodity Channel Index
      5.11. Williams R
      5.12. Moving Average Convergence Divergence (MACD)
      5.13. Appendices

      6. BUSINESS RISK ASSESSMENT
      6.1. Analysis Notes
      6.2. Business Risk Data
      6.3. Appendices

      7. MARKET FORECAST AND OPPORTUNITY ANALYSIS
      7.1. Analysis Notes
      7.2. Market Forecast and Opportunity Analysis: Summary
      7.3. Market Forecast and Opportunity Analysis: Base Scenario
      7.4. Market Forecast and Opportunity Analysis: Conservative Scenario
      7.5. Market Forecast and Opportunity Analysis: Optimistic Scenario

      8. ANALYSIS OF RETURNS ON INVESTMENT
      8.1. Analysis Notes

      POWERPOINT DELIVERABLE

      1. CONTEXT

      2. PROJECT APPROACH

      3. PROJECT OBJECTIVES

      4. EXECUTIVE SUMMARY

      Section I: Introduction to RNA Therapeutics and Innovators Landscape

      5. THE RNA THERAPEUTICS MARKET
      5.1. Overview
      5.2. Types of RNA Therapeutics
      5.3. Historical Development
      5.4. Applications of RNA Therapeutics
      5.5. Benefits of RNA Therapeutics
      5.6. Challenges Associated with RNA Therapeutics
      5.7. Contemporary Sentiments and Expert Opinions

      6. RNA THERAPEUTICS: INNOVATORS LANDSCAPE
      6.1. Methodology
      6.2. Innovators in the RNA Therapeutics Market
      6.3. Analysis of Innovators Landscape
      6.4. Concluding Remarks

      7. RNA THERAPEUTICS: PRODUCTS LANDSCAPE AND COMPANY HEALTH INDEXING
      7.1. List of RNA Therapeutics
      7.2. Analysis of Products Landscape
      7.3. Company Health Indexing Methodology
      7.4. Company Health Indexing Scoring
      7.5. Company Health Indexing

      8. VALUE PROPOSITION ANALYSIS
      8.1. Overview and Methodology
      8.2. Value Proposition Analysis: Therapy-related Aspect
      8.3. Value Proposition Analysis: Developer-related Aspect
      8.4. Value Proposition Analysis: Technology-related Aspect
      8.5. Value Proposition Analysis: Patient-related Aspect
      8.6. Concluding Remarks

      9. COMPANY COMPETITIVENESS ANALYSIS
      9.1. Overview and Methodology
      9.2. Company Competitiveness Analysis
      9.3. Concluding Remarks

      Section II: Analysis of Investments and Company Valuation

      10. FUNDING AND INVESTMENT ANALYSIS
      10.1. Overview
      10.2. Analysis by Type of Funding
      10.3. Analysis by Geography and Most Active Companies
      10.4. Analysis of Trends Associated with Individual Funding Categories
      10.5. Funding and Investments Summary

      11. COMPANY VALUATION ANALYSIS
      11.1. Overview and Methodology
      11.2. Valuation of Public Companies
      11.3. Company Valuation: Based on Company Size
      11.4. Company Valuation: Based on Latest Stage of Financing
      11.5. Company Valuation: Based on Company Size and Latest Stage of Funding

      Section III: Financial Analysis and Assessment of Business Risks

      12. FINANCIAL ANALYSIS OF PUBLIC VENTURES
      12.1. Fundamental Financial Analysis Overview
      12.2. Financial Ratios (Interpretation Guide)
      12.3. Fundamental Financial Analysis: List of Public Companies

      13. COMPANY PROFILES OF PUBLIC VENTURES
      13.1. Arbutus Biopharma
      13.2. Arcturus Therapeutics
      13.3. GreenLight Biosciences
      13.4. Gritstone bio
      13.5. IVERIC bio
      13.6. Moderna
      13.7. Omega Therapeutics
      13.8. Phio Pharmaceuticals
      13.9. Regulus Therapeutics
      13.10. Vir Biotechnology

      14. BUSINESS RISK ASSESSMENT
      14.1. Overview and Methodology
      14.2. Operations-related Risks
      14.3. Business-related Risks
      14.4. Financial / Asset-related Risks
      14.5. Product / Technology-related Risks
      14.6. Industry Specific Risks
      14.7. Other Risks
      14.8. Summary of Business Risk Assessment

      Section IV: Market Forecast and Opportunity Analysis

      15. MARKET FORECAST AND OPPORTUNITY ANALYSIS
      15.1. Overview and Methodology
      15.2. Global RNA Therapeutics Market, 2023-2035
      15.2.1. RNA Therapeutics Market: Analysis by Type of Therapy, 2023 and 2035
      15.2.2. RNA Therapeutics Market: Analysis by Therapeutic Area, 2023 and 2035
      15.2.3. RNA Therapeutics Market: Analysis by Route of Administration, 2023 and 2035

      Section V: Analysis of Returns on Investment and Key Acquisition Targets

      16. ANALYSIS OF RETURNS ON INVESTMENT
      16.1. Overview and Methodology
      16.2. Case Studies
      16.2.1. Avidity Biosciences
      16.2.2. BioNTech
      16.2.3. GreenLight Biosciences
      16.2.4. Gritstone bio
      16.2.5. IVERIC bio
      16.2.6. Moderna
      16.2.7. Regulus Therapeutics
      16.2.8. Vir Biotechnology
      16.3. Concluding Remarks

      17. KEY ACQUISITION TARGETS
      17.1. Overview
      17.2. List of Key Acquisition Targets
      17.3. Concluding Remarks

      18. CONCLUSION

      19. APPENDICES

      For more information about this report visit https://www.researchandmarkets.com/r/dsyexw

      About ResearchAndMarkets.com

      ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]
       
      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900
       
      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      Logo:https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.